Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial

BACKGROUND: Pimobendan is effective in treatment of dogs with congestive heart failure (CHF) secondary to myxomatous mitral valve disease (MMVD). Its effect on dogs before the onset of CHF is unknown. HYPOTHESIS/OBJECTIVES: Administration of pimobendan (0.4–0.6 mg/kg/d in divided doses) to dogs with...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Vet Intern Med
Auteurs principaux: Boswood, A., Häggström, J., Gordon, S.G., Wess, G., Stepien, R.L., Oyama, M.A., Keene, B.W., Bonagura, J., MacDonald, K.A., Patteson, M., Smith, S., Fox, P.R., Sanderson, K., Woolley, R., Szatmári, V., Menaut, P., Church, W.M., O'Sullivan, M. L., Jaudon, J.‐P., Kresken, J.‐G., Rush, J., Barrett, K.A., Rosenthal, S.L., Saunders, A.B., Ljungvall, I., Deinert, M., Bomassi, E., Estrada, A.H., Fernandez Del Palacio, M.J., Moise, N.S., Abbott, J.A., Fujii, Y., Spier, A., Luethy, M.W., Santilli, R.A., Uechi, M., Tidholm, A., Watson, P.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
SMALL ANIMAL
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115200/
https://ncbi.nlm.nih.gov/pubmed/27678080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14586
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires